2 completed, 1 terminated. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow George Albert Fisher: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer Gemcitabine, Dendritic Cell Immunotherapy - Pancreatic Cancer | Phase 1 | Completed | George Albert Fisher | 2 | 2005-10-01 | 2012-11-08 |
| Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic Cancer Vatalanib, Gemcitabine - Pancreatic Cancer | Phase 1 / Phase 2 | Completed | George Albert Fisher | 33 | 2004-10-01 | 2014-09-15 |
| A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer Cetuximab, Oxaliplatin, Capecitabine - Rectal Cancer, Colo-rectal Cancer | Phase 1 / Phase 2 | Terminated | George Albert Fisher | 23 | 2004-06-01 | 2017-12-08 |
Pancreatic Neoplasms (2) · Colonic Neoplasms (1) · Rectal Neoplasms (1)
Gemcitabine (2) · Capecitabine (1) · Cetuximab (1) · Diphenhydramine (1) · Doxylamine (1) · Oxaliplatin (1) · Radiotherapy (1) · vatalanib (1)
United States (3)
George Albert Fisher M.D. Ph.D. (2) · Branimir I Sikic, MD (1) · Edgar G Engleman (1) · George A Fisher, MD, PhD (1)